Rocky Mountain Cancer Center — Denver, Colorado

Rocky Mountain Cancer Center is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Center has participated in 96 clinical trials with 12 currently active.

Therapeutic areas: MPN (Myeloproliferative Neoplasms), Neoplasms, Non-Hodgkin Lymphoma.

Sponsors: Incyte Corporation, Cortice Biosciences, Inc., Eisai Inc..

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Center?

Rocky Mountain Cancer Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Center conducted?

Rocky Mountain Cancer Center has 96 clinical trials on record, with 12 currently active. Their work covers MPN (Myeloproliferative Neoplasms), Neoplasms, Non-Hodgkin Lymphoma.

Is Rocky Mountain Cancer Center accredited by Crixeo Health?

Rocky Mountain Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.